PwC PricewaterhouseCoopers / Venture Economics / National Venture Capital Association MoneyTree Survey March 2002 Venture Capital Investment in the Biotechnology Industry
PricewaterhouseCoopers/Venture Economics/National Venture Capital Association MoneyTree™ Survey 2 About The Quarterly MoneyTree Survey PricewaterhouseCoopers has joined forces with Venture Economics and the National Venture Capital Association to produce MoneyTree Survey ‘Core’ measure of equity investments in venture-backed companies in the United States Companies have received at least one round of financing involving a professional VC firm or equivalent Captures: tranches, not term sheets, foreign VCs, qualified private placement Excludes: debt, bridge loans, recaps, roll-ups, IPO's, Pipe's, leasing, etc. MoneyTree™ Survey in its 8th year Results online at
PricewaterhouseCoopers/Venture Economics/National Venture Capital Association MoneyTree™ Survey 3 Let’s put the role of venture capital in the biotechnology industry into perspective…
PricewaterhouseCoopers/Venture Economics/National Venture Capital Association MoneyTree™ Survey 4 Federal Non-Defense R&D Venture Financing Exceeds Federal Non- Defense R&D Budget Source: PwC/VE/NVCA MoneyTree™ Database & AAAS Report Citing 2002 Federal Budget. Note Federal R&D statistics are constant 2001 dollars
PricewaterhouseCoopers/Venture Economics/National Venture Capital Association MoneyTree™ Survey 5 MoneyTree: Total Investments in Biotechnology ($ in billions) # of Deals % of all Investments 10% 11.4%13.6% 6.9% 3.7%3.5%8.1%
PricewaterhouseCoopers/Venture Economics/National Venture Capital Association MoneyTree™ Survey 6 Texas $ Deals Silicon Valley $3, Deals New England $2, Deals Midwest $ Deals South Central $ Deals Northwest $ Deals Sacramento/N. CA $ Deals San Diego $1, Deals Biotechnology Investments by Region Southeast $ Deals Southwest $ Deals LA/Orange County $ Deals DC/Metroplex $ Deals NY Metro $ Deals Philadelphia Metro $ Deals North Central $ Deals ($ in millions) Colorado $ Deals Alaska/ Hawaii $0 0 Deals
PricewaterhouseCoopers/Venture Economics/National Venture Capital Association MoneyTree™ Survey 7 Texas 0 Deals Silicon Valley $ Deals New England $ Deals Midwest $42 5 Deals South Central 0 Deals Northwest $20 2 Deals Sacramento/N. CA 0 Deals San Diego $82 6 Deals Biotechnology Investments by Region Q Southeast $9 3 Deals Southwest $2 2 Deals LA/Orange County $23 3 Deals DC/Metroplex $98 5 Deals NY Metro $174 3 Deals Philadelphia Metro $55 4 Deals North Central $13 5 Deals Total: $1,004 – 67 deals ($ in millions) Colorado $65 1 Deal Alaska/ Hawaii $0 0 Deals
PricewaterhouseCoopers/Venture Economics/National Venture Capital Association MoneyTree™ Survey 8 Investments by Industry Q # of Deals % Change in $ Amount from Q3 01 ($ in millions) Visit for Industry Definitions Q Totals: $7, % % 41.6% (22.7%) (9.9%) (3%) (21.3%) (43.6%) (23.7%) 7.2% (2.7%) NM 46.1% (31.4%) % NM 86% ( NM = Not Meaningful)
PricewaterhouseCoopers/Venture Economics/National Venture Capital Association MoneyTree™ Survey 9 Investments by Industry - Percent of Total U.S. Investments Top 5 Industries – 1995 to 2001 (% of Total Dollars) ‘95‘96‘98‘99‘00‘97‘01 ‘95‘96‘97‘99 ‘98 ‘00‘01‘95‘96‘97‘98 ‘95‘01‘00‘99‘96‘95‘96‘97’98‘99‘00‘01‘97‘98‘99‘00‘01
PricewaterhouseCoopers/Venture Economics/National Venture Capital Association MoneyTree™ Survey 10 Life Science Investments - Percent of Total U.S. Investments Life Science Sectors – 1995 to 2001 (% of Total Dollars) ’95’96‘97‘96‘98‘99‘00‘01‘97‘98 ‘95 ‘99‘00‘01 ‘96‘97‘98‘99‘00‘01
PricewaterhouseCoopers/Venture Economics/National Venture Capital Association MoneyTree™ Survey 11 Biotechnology Investments by Financing Sequence - Q # of Deals % Change in $ Amount from Q3 01 ($ in millions) * Abnormally high change due to a $150 million investment and a $70 million investment % (22%) (40%) 636%* 48%
PricewaterhouseCoopers/Venture Economics/National Venture Capital Association MoneyTree™ Survey 12 ($ in millions) Average Biotechnology Deal Size Compared to Average Deal Size for all Industries
PricewaterhouseCoopers/Venture Economics/National Venture Capital Association MoneyTree™ Survey 13 Venture Capital FirmLocationTotal Deals J.P. Morgan PartnersMenlo Park, CA 13 MPM CapitalCambridge, MA 13 Oxford Bioscience Partners Menlo Park, CA 11 Alta Partners San Francisco, CA 9 Domain Associates Princeton, NJ 9 8 Sprout Group New York, NY Boston, MA 10 InterWest Partners Most Active Venture Investors in Biotechnology Princeton, NJ Healthcare Ventures LLC
PwC Our Core Biotechnology Service Team: Frank Feeman, audit partner 206/ Jon Kuchin, tax partner 206/ Dick Ottele, audit senior manager 206/
PwC pwc